AbbVie Inc (ABBV)
Working capital turnover
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (ttm) | US$ in thousands | 54,318,000 | 55,138,000 | 56,023,000 | 56,741,000 | 58,054,000 | 57,819,000 | 57,349,000 | 56,725,000 | 56,197,000 | 55,169,000 | 53,729,000 | 50,195,000 | 45,804,000 | 40,650,000 | 36,227,000 | 34,057,000 | 33,266,000 | 32,867,000 | 32,624,000 | 32,647,000 |
| Total current assets | US$ in thousands | 33,002,000 | 33,224,000 | 28,852,000 | 26,488,000 | 28,463,000 | 30,364,000 | 29,100,000 | 26,509,000 | 27,928,000 | 28,957,000 | 25,999,000 | 26,569,000 | 24,173,000 | 23,009,000 | 21,256,000 | 51,758,000 | 49,519,000 | 20,166,000 | 15,100,000 | 14,413,000 |
| Total current liabilities | US$ in thousands | 37,841,000 | 34,773,000 | 32,239,000 | 27,590,000 | 29,538,000 | 32,712,000 | 34,473,000 | 32,521,000 | 35,194,000 | 28,533,000 | 28,684,000 | 31,951,000 | 28,661,000 | 24,181,000 | 24,646,000 | 16,471,000 | 15,585,000 | 17,493,000 | 16,941,000 | 13,904,000 |
| Working capital turnover | — | — | — | — | — | — | — | — | — | 130.12 | — | — | — | — | — | 0.97 | 0.98 | 12.30 | — | 64.14 |
December 31, 2023 calculation
Working capital turnover = Revenue (ttm) ÷ (Total current assets – Total current liabilities)
= $54,318,000K ÷ ($33,002,000K – $37,841,000K)
= —
Working capital turnover is a financial ratio that measures the efficiency of a company in managing its working capital to generate sales. It is calculated by dividing the net sales by the average working capital over a certain period.
Since there is no specific data provided for the working capital turnover of Abbvie Inc in the given table for the quarters of 2023 and 2022, it is not possible to perform a detailed analysis of this ratio for the company during these periods.
For a comprehensive analysis of Abbvie Inc's working capital turnover, it would be necessary to have access to the net sales and working capital figures for each quarter to compute the ratio and evaluate its trend over time. In the absence of this data, further insights into the company's efficiency in managing its working capital to generate sales cannot be provided.
Therefore, it is recommended to obtain the necessary financial information to calculate the working capital turnover for Abbvie Inc and conduct a thorough analysis to assess the company's operational effectiveness in utilizing its working capital resources.
Peer comparison
Dec 31, 2023